Thomas Maal is the first professor of 3D Technology in Healthcare. In 2006, together with Professor S.J. Bergé, he founded the 3D Lab in Nijmegen. The 3D Lab aims for the continuous improvement of 3D technology in healthcare.The new possibilities this offers, such as patient-specific virtual preparation for surgery and 3D-printed anatomical models, mean that care and treatment plans can be tailored to the specific wishes and circumstances of patients. Treatments are shortened, fewer operations are needed, operations are of higher quality and patients recover faster. This has a major impact for individual patients and reduces healthcare costs. Thomas Maal has been appointed professor at Radboud university medical center with effect from 1 November 2018.
“When imagining the 3D Lab, many people think of a room full of 3D printers, but we do a lot more than that”, says Maal, coordinator of the 3D Lab since 2012. “In addition to 3D printing, we are involved in robotics and augmented reality. These technologies play an increasingly more important role in healthcare. For example, 3D imaging and 3D printing are valuable techniques for identifying disorders: we can obtain a better, three-dimensional image of the situation and can therefore make a better diagnosis. We can also prepare operations in 3D and evaluate results accurately. In this way an optimal patient-specific solution is created.”
Fewer additional operations
Surgeons can work much more accurately with operations that are planned in 3D. Maal: “The surgical error rates have decreased substantially. This means that fewer additional operations are needed. With 3D support you can place implants with high precision, for example after a leg amputation. As a result, patients can regain their ability to walk more quickly and effectively.” According to Maal, the 3D technique is also more patient-friendly, for example for people who switch from a denture to a dental implant. In the past, after the operation, patients remained toothless for three to six months. Now they receive a 3D-printed implant immediately after the procedure.
As a professor, Maal is committed to the further implementation of 3D technology in healthcare. He will continue his line of research and look for innovative 3D technologies to change and improve patient care. In addition, he will expand the existing national network. As a result, more patients in the Netherlands and beyond will be able to benefit from the great possibilities offered by 3D technology.
In 2006, Thomas Maal started using 3D photography at the Department of Oral and Maxillofacial Surgery at Radboud university medical center; since 2012 he has been a staff member and coordinator of the 3D Lab. In 2013 he also became coordinator of the 3D lab at AMC Amsterdam. The 3D Lab now employs 15 engineers from various backgrounds, from technical physicians to game specialists. Besides the Department of OMS, 15 other departments at Radboud university medical center are now benefitting from these new technologies. The 3D Lab also cooperates nationally with some 15 general hospitals and four UMCs.
Thomas Maal is member within the theme of Reconstructive and regenerative medicine.
Related news items
Jong KNCV organizes a Pitch competition for PhD candidates13 August 2020
Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.read more
Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels13 August 2020
Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.read more
TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer12 August 2020
An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.read more
BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea11 August 2020
The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.read more
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more